nature neurOSCIenCe a r t I C l e S Individuals suffering from addiction endure large personal and financial losses to maintain drug use. Among other addictive behaviors, they show a strong perseverance and an extraordinary motivation to obtain the drug. These behaviors are expressed by only a fraction of those exposed to the drug, revealing a substantial degree of individual variability and the existence of predisposing traits and conditions that may serve as risk or protective factors in the development of addiction. In humans, the vulnerability to develop compulsive behaviors toward stimulant drugs has been linked to deficits in cortico-striatal processing and low levels of dopamine D2 receptors in the striatum [1] [2] [3] . Moreover, impulsivity traits and low levels of dopamine D2 receptors have been associated with compulsive cocaine use in both rodents and nonhuman primates 4, 5 . Furthermore, rodents also show natural individual variability in the motivational properties of cocaine and the development of compulsive behaviors [6] [7] [8] . Dopamine D2 receptors are expressed in the subpopulation of medium spiny neurons (D2-MSNs) in the striatum that form indirect projections to midbrain regions via pallidum and subthalamic nuclei (indirect pathway). The other subpopulation of MSNs expresses dopamine D1 receptors (D1-MSNs) and forms direct projections to midbrain neurons (direct pathway). Activation of dopamine receptors on each subpopulation of MSNs triggers different intracellular signaling cascades. Activation of D2 receptors inhibits PKA activity via G i signaling in D2-MSNs, whereas activation of D1 receptors stimulates PKA activity via G s/olf signaling in D1-MSNs 9 . It is thought that these two MSN subtypes and their parallel pathways exert complementary, and sometimes opposing, actions on behaviors that are controlled by the cortico-striatal system 10 . The use of pharmacological tools that target D1 and D2 receptors has helped to determine the relative contribution of the direct and indirect pathways in behavior. However, the complex expression pattern of dopamine D2 receptors present in both pre-and postsynaptic compartments in different neuronal types in the mesolimbic circuit has complicated the interpretation of these experimental results.
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Dopamine D2 receptors are expressed in the subpopulation of medium spiny neurons (D2-MSNs) in the striatum that form indirect projections to midbrain regions via pallidum and subthalamic nuclei (indirect pathway). The other subpopulation of MSNs expresses dopamine D1 receptors (D1-MSNs) and forms direct projections to midbrain neurons (direct pathway). Activation of dopamine receptors on each subpopulation of MSNs triggers different intracellular signaling cascades. Activation of D2 receptors inhibits PKA activity via G i signaling in D2-MSNs, whereas activation of D1 receptors stimulates PKA activity via G s/olf signaling in D1-MSNs 9 . It is thought that these two MSN subtypes and their parallel pathways exert complementary, and sometimes opposing, actions on behaviors that are controlled by the cortico-striatal system 10 . The use of pharmacological tools that target D1 and D2 receptors has helped to determine the relative contribution of the direct and indirect pathways in behavior. However, the complex expression pattern of dopamine D2 receptors present in both pre-and postsynaptic compartments in different neuronal types in the mesolimbic circuit has complicated the interpretation of these experimental results.
Cell type-specific approaches have recently been used to aid in this quest. In the dorsal striatum, optogenetic activation of direct pathway D1-MSNs increases locomotion and serves as a reinforcer, whereas activation of indirect pathway D2-MSN increases freezing behaviors and is not a reinforcer 11, 12 . In the NAc, a region involved in cue-induced reward learning, D1-MSNs and D2-MSNs have opposite effects on cocaine-related behaviors 9 . Activation of D2-MSNs reduces conditioned place preference for cocaine, whereas activation of D1-MSN increases it 13 . In addition, the ablation or inhibition of D2-MSNs in the NAc induces an increase in amphetamine conditioned place preference and facilitates locomotor sensitization to cocaine, suggesting a tonic role of D2-MSNs on limiting the actions of stimulant drugs 14, 15 .
However, despite these findings, the role of the indirect pathway and D2-MSNs in voluntary cocaine self-administration and compulsive drug seeking remains unclear. We predicted that indirect-pathway D2-MSNs would exert an inhibitory influence on behavioral output of this circuitry and limit drug seeking, and that weakening this pathway would remove the inhibitory control and render individuals more susceptible to develop compulsive drug seeking. We found individual variability in vulnerability to compulsive cocaine use that was correlated to the synaptic strength of inputs to D2-MSNs. Moreover, inhibition or activation of the accumbal indirect pathway enhanced or suppressed cocaine self-administration behavior, respectively. a r t I C l e S RESULTS Individual variability in behaviors toward cocaine Intravenous cocaine self-administration was established in an outbred strain of mice using a cued-operant task that required naive mice to nose poke in an active hole to earn an intravenous infusion of cocaine ( Supplementary Fig. 1 ). Approximately 55% of mice acquired the behavior within 5-10 d and the rest were removed from the study. Mice were then given access to cocaine during daily 2-h sessions for 6-7 weeks. Two behaviors were measured to determine the degree of compulsive drug use: the difficulty of stopping or limiting drug use, measured as perseverative drug seeking, and high motivation to obtain the drug, measured as the effort exerted to obtain it. These behaviors were adopted from the diagnostic criteria for drug dependence in humans described in the DSM-IV and have been successfully applied in a model developed in rats 4, 7, 16 .
To measure perseverative responding, we interrupted sessions with two drug-off periods (15 min long), during which cocaine was not available (Fig. 1a-c) . Initially, mice showed a typical extinction response during the drug-off periods that was characterized by a spike in responding on days 1 and 2, followed by a decrease in responding selectively in the drug-off periods during subsequent days. Although most mice maintained minimal responding for the rest of the sessions, a few developed perseverative responding after weeks of selfadministration ( Supplementary Fig. 2 ). The perseverance value was calculated as mean active pokes during the drug-off periods over the last ten sessions (Fig. 1c) . During this time, perseverative responding during the drug-off period was selective to the active nose pokes and the number of inactive pokes was similar between mice with high and low perseverance values (0.13 ± 0.07 inactive pokes per day for mice with perseverance value > 2, n = 3 mice; 0.27 ± 0.08 inactive per day for mice with values < 2, n = 24 mice; unpaired t test, t 24 = 0.5, P = 0.62).
Motivation to obtain cocaine was assessed in two progressive ratio sessions in which the number of pokes required to earn each consecutive cocaine reward was increased exponentially (Online Methods and Fig. 1d,e) . The breakpoint, the number of pokes performed to earn the last reward, was defined as the motivation value. Similar to the measure of perseverative behavior, most mice showed low motivation values, but a few mice had high values (Supplementary Fig. 2) . Notably, the ratio of inactive to active pokes did not change during these progressive ratio sessions (session, 0.27 ± 0.04; progressive ratio 0.48 ± 0.17; paired t test, t 26 = 1.2, P = 0.23, n = 27 mice).
A combined behavior score was calculated for each mouse by adding the z score of perseverance and motivation values. By definition, z scores have a mean of zero and a s.d. of 1, which ensures equal contribution of each behavior and eliminates inherent differences in the variance of each measurement. Mice varied on the degree of perseverance, motivation and combined behavior score, as well as on their average cocaine intake through the study (5-24 mg per kg of body weight per d). However, there was no correlation between the perseverance scores and cocaine intake (r P = 0.27, r 2 = 0.08, P = 0.16, n = 27 mice; Fig. 1f) . Although the highest perseverance score was observed in a mouse with a daily intake of 20 mg per kg of cocaine, high intake was not sufficient to predict positive perseverance scores. As expected, there was a positive correlation between the motivation and the combined behavior scores and daily cocaine intake (motivation score: r P = 0.57, r 2 = 0.31, P < 0.01, n = 27 mice; combined score: r P = 0.49, r 2 = 0.24, P < 0.01, n = 27 mice; Fig. 1g,h) . A mean daily intake of 10 mg per kg per d, a dose that increases locomotion in this mouse strain 17 , was used as the threshold to identify mice with high and low cocaine intake. Mice with low daily cocaine intake displayed mean negative motivation scores (−0.5 ± 0.1) and behavior scores (−0.7 ± 0.2, n = 13 mice), whereas mice with high cocaine intake showed mean positive motivation (0.5 ± 0.3) and behavior scores (0.6 ± 0.6, n = 14 mice) (Fig. 1g,h ). Despite the correlation between intake and the behavior scores, there was a considerable degree of variability in the scores among mice with high intake. High intake did not always result in the development of compulsive cocaine use, and some mice maintained negative behavior scores. We asked whether specific synaptic mechanisms are associated with and responsible for the vulnerability or resistance to develop compulsive behaviors among cocaine users.
Potentiation of excitatory synapses onto D1-MSNs
We examined glutamatergic excitatory transmission in direct-pathway D1-MSNs and indirect-pathway D2-MSNs in the NAc core region of ex vivo brain slices. These neurons received dense innervation from cortical regions that were activated by electrical stimulation. The expression of GFP was used to discriminate between fluorescently labeled D1-MSNs and unlabeled putative D2-MSNs (Fig. 2a,b) . Recordings were made from 30 mice that underwent at least 17 sessions of cocaine self-administration (22 of these with behavioral scores) and 20 sham surgery mice. In general, we recorded from D1-MSNs in some mice and D2-MSNs in others, although recordings were obtained from both D1-MSNs and D2-MSNs in a small subset of cocaine-exposed mice (Supplementary Table 1 ). In cocaine-exposed mice, the ratio of AMPA/NMDA excitatory postsynaptic currents (EPSCs) was increased selectively in D1-MSNs, but not in D2-MSNs, compared with sham controls (D1-MSNs: cocaine, 2.77 ± 0.28, n = 46 cells from 23 mice; sham, 1.93 ± 0.26, n = 27 cells from 15 mice; Mann-Whitney test U = 415, P = 0.018; D2-MSNs: cocaine, 2.74 ± 0.31, n = 29 cells from 18 mice; sham, 2.25 ± 0.27, n = 23 cells from 15 mice, Mann-Whitney test U = 312, P = 0.20; Fig. 2c-e) .
We further investigated this increase in the ratio of D1-MSNs using two-photon uncaging of glutamate at single spines to measure the AMPA and NMDA receptor-mediated currents at individual spines ( Fig. 2f-h ). The amplitudes of AMPA receptor uncaging-evoked EPSCs (uEPSCs) in cocaine-exposed mice had a tendency to be larger than those in sham mice (sham, 23.3 ± 4.3 pA, n = 24 spines from 9 cells; cocaine, 32.9 ± 4.6 pA, n = 23 spines from 13 cells; MannWhitney test U = 195, P = 0.09 for two-tail and P = 0.04 for one-tail; Fig. 2i ), whereas the amplitudes of NMDA receptor uEPSCs were similar in sham and cocaine-exposed mice (sham, 6.4 ± 0.7 pA, n = 22 spines from 6 cells; cocaine, 5.9 ± 0.8 pA, n = 20 spines from 5 cells; unpaired t test, t 40 = 0.26, P = 0.79; Fig. 2i) . A rightward shift in the amplitude distribution of AMPA receptor uEPSCs was seen in cocaine-exposed mice, indicating that there was a smaller percentage of spines with currents that were undistinguishable from noise (<5 pA uEPSC; cocaine, 4%; sham, 12.5%; Fig. 2j) , and a greater percentage of spines with large AMPA receptor uEPSCs (>15 pA uEPSC; cocaine, 65%; sham, 33%; Supplementary Fig. 3c ). Furthermore, we observed an increase in spine head width, but not length, in D1-MSNs after cocaine exposure (thin spines: sham, 0.81 ± 0.03 µm, n = 23 spines; cocaine, 0.89 ± 0.03 µm, n = 22 spines; wide spines: sham, 1.17 ± 0.04 µm, n = 23 spines; cocaine, 1.32 ± 0.06 µm, 22 spines; two-way ANOVA, no interaction, F 1,68 = 0.6, P = 0.4; effect of width, F 1,68 = 99.6, P < 0.01; effect of treatment, F 1,68 = 8.4, P < 0.05; Bonferroni post hoc wide spines sham versus cocaine P < 0.05, thin spines sham versus cocaine P > 0.05; Supplementary Fig. 3a-c) . These results suggest that the enhancement of the AMPA/NMDA ratio observed in D1-MSNs from cocaine-exposed mice is a result of a potentiation of AMPA receptor-mediated currents at excitatory synapses.
Potentiation at D2-MSNs only in those with negative scores Although inputs to D2-MSNs did not show potentiation in the majority of mice, analysis of individual mice revealed that a fraction of cocaine-exposed mice showed an increase in the AMPA/NMDA ratio in D2-MSNs (Fig. 3a) . Among mice with high daily cocaine intake, we found a strong negative correlation between the behavior scores No correlation was observed between D1-MSNs and the behavior scores (r P = −0.02, r 2 <0.01, P = 0.95, n = 15 mice; Fig. 3d ,e). Mice with positive and negative behavior scores had similar AMPA/NMDA ratios, and synaptic potentiation in D1-MSNs was therefore not correlated with the development of compulsive cocaine intake (positive, ratio = 2.9 ± 0.7, behavior score = 1.4 ± 0.8, n = 8 mice; negative, ratio = 3.2 ± 0.5, behavior score = −0.87 ± 0.2, n = 7 mice; sham, ratio = 1.9 ± 1.1, n = 15 mice; one-way ANOVA, F 2,20 = 2.8, P > 0.05; Fig. 3f ).
D2-MSN inhibition enhances motivation for cocaine
These findings indicate that excitatory inputs with higher AMPA/ NMDA ratios are present in D2-MSNs of individuals that did not develop compulsive behaviors toward cocaine, suggesting that potentiation of excitatory inputs onto D2-MSNs might confer protection against cocaine-related behaviors. We reasoned that weakening of the indirect pathway may render individuals more vulnerable to the expression of compulsive behavior toward cocaine. To test this hypothesis, we manipulated the activity of D2-MSNs using a chemicogenetic approach with designer receptor exclusively activated by a designer drug (DREADD) 18, 19 . hM4D i is a G i -coupled DREADD that has been used to inhibit MSN activity in the striatum 15, 20 . A conditional viral vector expressing hM4D i was injected bilaterally in the NAc core of mice expressing Cre recombinase selectively in D2-MSNs (Adora2a-cre +/− mice). Fluorescently tagged DREADDs were expressed at the soma of MSNs in the NAc core region around the anterior commissure and on axonal projections to the ventral pallidum (Fig. 4a,b) . No labeling was seen in other brain regions.
The inhibitory action of hM4D i on the indirect pathway was confirmed with recordings from ventral pallidum neurons. Synaptic responses were triggered by selective activation of fibers from D2-MSNs in the NAc that coexpressed channelrhodopsin-2 (ChR2) and hM4D i (injected at a 1:1 ratio). A laser pulse evoked GABAergic inhibitory postsynaptic currents (IPSCs) that were depressed by 52.5 ± 3.7% when the synthetic agonist for hM4D i , clozapine N-oxide (CNO, 10 µM), was applied (paired t test, t 6 = 4.0, P < 0.01, n = 7 cells; Fig. 4c,d ). Application of CNO had no effect on the amplitudes of IPSCs in slices expressing only ChR2 in D2-MSN (data not shown). These results indicate that activation of hM4D i expressed in accumbal D2-MSNs inhibits the output of the accumbal-tegmental indirect pathway.
Mice expressing hM4D i in D2-MSNs in the NAc were allowed to acquire cocaine self-administration behavior for 9 d. We first examined the effect of D2-MSN inhibition on sessions in which the drug was easily accessible under a fixed poke:reward ratio of 1 (FR1). Mice alternately received CNO (1 mg per kg) and saline intravenously immediately before the session (Fig. 4e) . The two groups showed similar daily cocaine intake (saline = 31 ± 2.9 mg per kg per d; CNO = 34 ± 2.3 mg per kg per d, paired t test, t 13 = 0.86, P = 0.24, n = 6 mice; Fig. 4f ), suggesting that inhibition of the D2-MSNs output did not alter cocaine intake when the drug was available with minimum effort. The motivation to obtain cocaine was tested in 4-6 consecutive progressive ratio sessions in which the pokes:reward ratio was increased exponentially with each subsequent reward. Notably, during these sessions, drug intake dropped to 10-40% of the normal intake during sessions with low-effort access to cocaine (FR1). Following a latin-square design, CNO or saline was administered intravenously immediately before the session. Mice had different breakpoint values on control saline days (Fig. 4g) , which reflected the individual differences in the motivation for cocaine (Fig. 1) . However, independently of their baseline breakpoint, mice had more active pokes and achieved higher breakpoint on days in which they were treated with CNO (breakpoint: saline = 18.7 ± 6.1, CNO = 35.4 ± 12.3, n = 6, paired t test, t 5 = 2.6, P < 0.05). When normalized to saline, the breakpoint doubled on CNO days, indicating a higher motivation to obtain cocaine following inhibition of D2-MSNs (normalized breakpoint in CNO = 2 ± 0.2, one-sample t test, t 5 = 2.7, P < 0.02; Fig. 4g ). Table 1 ). *P < 0.05, one-way ANOVA followed by Bonferroni. npg a r t I C l e S 6 3 6 VOLUME 16 | NUMBER 5 | MAY 2013 nature neurOSCIenCe Treatment with CNO had no effect on breakpoint values in control mice that received intracranial injection, but did not express hM4Di (Adora2a-cre −/− mice or Adora2a-cre +/− mice with unsuccessful injections), ruling out a nonspecific effect of CNO on performance (breakpoint: saline = 41.5 ± 18.2, CNO = 33.9 ± 16.9, paired t test, t 3 = 1.3, P > 0.2, n = 4 mice; breakpoint in CNO normalized to saline = 0.78 ± 0.16, one sample t test, t 3 = 1.35, P = 0.27; Supplementary Fig. 4a ).
When hM4Di was expressed in D2-MSNs of the dorsal striatum, CNO treatment did not increase breakpoint values, suggesting a selective regulation by NAc neurons of cocaine seeking during the first weeks after acquisition of the behavior (breakpoint: saline = 59.2 ± 24.1, CNO = 66.8 ± 23.6, paired t test, t 5 = 0.5, P > 0.6, n = 6; breakpoint in CNO normalized to saline = 1.2 ± 0.2, one sample t test, t 5 = 1.3, P > 0.2; Supplementary Fig. 4b,c) .
Activation of G i signaling in D2-MSNs can also be achieved by administration of D2 receptor agonists. However, D2 receptors are also expressed in other cell types, including striatal cholinergic interneurons and midbrain dopaminergic neurons, where activation of these receptors inhibits dopamine release 21 . Systemic administration of the D2-like agonist quinelorane failed to increase breakpoint values for cocaine during progressive responding sessions (saline = 35 ± 9.5, quinelorane = 28 ± 13.4, n = 5 mice, paired t test, t 4 = 1.1, P > 0.3; Fig. 4h) . In contrast, a trend to decreased responding for cocaine was observed in these experiments when a low dose of quinelorane (30 µg per kg) was administered intravenously before the start of the session (normalized breakpoint in quinelorane = 0.59 ± 0.24%, one-sample t test, t 4 = 1.67, P = 0.17, n = 5 mice; Fig. 4h ). This dose was chosen because higher doses of D2 receptor agonist depress locomotor activity in mice 22 , which would interfere with the task. This result is consistent with previous reports that D2-like agonists produce a leftward shift in the dose-response curve for cocaine self-administration and decrease overall cocaine intake in rats and nonhuman primates [23] [24] [25] .
This same activity manipulation had no effect on responding when mice were trained on a cued-instrumental task to earn a food reward (Supplementary Fig. 5 ). Adora2a-cre +/− mice expressing hM4D i in NAc D2-MSNs (n = 3 mice) and sham surgery control Adora2a-cre −/− mice (n = 4 mice) were trained on a fixed ratio schedule and the effect of CNO on responding for food rewards was assessed under fixed ratio and progressive ratio schedules. Food rewards earned under fixed ratio were similar on days on which mice received saline and CNO in both genotypes (rewards per h in Adora2a-cre +/− mice: saline = 54 ± 10, CNO = 53 ± 11; Adora2a-cre +/− mice: saline = 57 ± 6, CNO = 54 ± 10; no interaction or effect in repeated-measure two-way ANOVA, all F's < 0.1, P's > 0.1; Supplementary Fig. 5b ). When normalized to rewards earned on saline days, food rewards earned on CNO days were comparable between genotypes (Adora2a-cre +/− mice = 1.0 ± 0.1, Adora2a-cre −/− mice = 1.06 ± 0.1, unpaired t test, t 12 = 0.34, P = 0.7; Supplementary Fig. 5c ). CNO had no effect during progressive ratio sessions, and sham mice and mice expressing hM4D i achieved similar breakpoints for food on saline and CNO days (Adora2a-cre +/− mice: saline = 983 ± 362, CNO = 829 ± 277; Adora2a-cre −/− mice: saline = 950 ± 153, CNO = 1,341 ± 388; no interaction or effect in repeated-measure two-way ANOVA, all F 1,5 's <0.8, P's > 0.4; Supplementary Fig. 5d ). Normalized CNO breakpoints were similar between genotypes (Adora2a-cre +/− mice = 0.98 ± 0.3, Adora2a-cre −/− mice = 1.7 ± 0.8, unpaired t test, t 5 < 0.98, P > 0.4; Supplementary Fig. 5e ), supporting our findings that inhibition of accumbal D2-MSNs did not affect motivation for food reinforcement. Furthermore, striatal D1 receptor expression and function appeared to be unaltered in mice that expressed hM4D i in the striatum and received repeated CNO treatment (1 mg per kg for 2-4 d; Supplementary Fig. 6 ).
D2-MSN activation suppresses cocaine self-administration
In vivo optogenetic stimulation was used to selectively activate D2-MSNs in the NAc core and test the effect of accumbal indirect pathway stimulation on cocaine self-administration. We bilaterally injected a npg a r t I C l e S conditional viral vector expressing ChR2 (EYFP tagged) into the NAc core region of Adora2a-cre +/− mice and implanted fiber optics in the injection area. Pathway-specific expression of ChR2 was confirmed using fluorescent microscopy, which revealed labeled cell bodies in the NAc core and labeled projections in the ventral pallidum, but not in other brain regions (Fig. 5a) . Electrophysiological recordings in brain slices containing NAc core showed that brief laser stimulation (0.5-ms duration pulse at 16.6 Hz) reliably triggered the firing of action potentials in D2-MSNs expressing ChR2 and, as expected, the firing was sensitive to tetrodotoxin (TTX; n = 2 cells; Fig. 5b ). The same brief laser stimulation elicited an IPSC in two types of neurons that are known to receive inputs from indirect pathway D2-MSNs: neighboring striatal MSNs (ChR2-negative, putative D1-MSNs, n = 3 cells) and ventral pallidum neurons (n = 9 cells; Fig. 5c,d) . Application of the GABA A receptor antagonist gabazine (5 µM) abolished the laser-evoked IPSCs in both cell types (n = 2 for both cell types). These results confirm that optogenetic stimulation activates accumbal indirect pathway neurons and, in turn, inhibits the postsynaptic targets of D2-MSNs. Mice expressing ChR2 in accumbal D2-MSNs were allowed to acquire cocaine self-administration behavior (5-9 d) and then habituated to perform with the optic fibers until responding was stable. Testing occurred over four consecutive daily sessions in which the laser power was OFF or ON, following the same pattern for all mice (OFF-ON-OFF-ON; Fig. 5e ). In the first set of experiments, optogenetic stimulation (10-ms pulses at 16.6 Hz, 10 min OFF followed by 5 min ON throughout the session) was delivered to the NAc core. Under these conditions, the mean number of earned rewards dropped significantly during ON sessions for all mice (OFF rewards per session = 21.8 ± 4.3, ON rewards per session = 7.3 ± 2.1, paired t test, t 7 = 4.5, P < 0.01, n = 8 mice; Fig. 5f ). When normalized to the OFF sessions, optogenetic stimulation suppressed cocaine self-administration by 69.1 ± 5.3% (one-sample t test, t 7 = 12.6, P < 0.001, n = 8 mice; Fig. 5f ). Furthermore, stimulation resulted in a similar decrease in mice trained on a FR1, FR2 and FR3 schedule (FR1: off = 18 ± 7.5, on = 6.5 ± 4, n = 2 mice; FR2: off = 25.7 ± 8.5, on = 7.8 ± 1.2, n = 3 mice; FR3: off = 20.5 ± 8.3, on = 7.3 ± 5.8, n = 3 mice; two-way repeated-measure ANOVA main effect of stimulation, F 1,5 = 15.25, P < 0.02; no effect of fixed ratio schedule or interaction, both F's < 0.3, P's > 0.7). These results indicate that recruitment of the indirect pathway reduces cocaine self-administration independent of the ratio requirement.
DISCUSSION
We found that resilience to compulsive cocaine use was accompanied by potentiation of glutamatergic inputs to D2-MSNs in the NAc, suggesting that this synaptic potentiation serves a protective mechanism. We challenged this conclusion by manipulating the activity of indirect-pathway D2-MSNs. Inhibition of D2-MSNs during selfadministration enhanced responding and increased motivation to obtain cocaine, rendering mice more vulnerable to the expression of compulsive behaviors. In contrast, activation of D2-MSNs decreased cocaine self-administration. These experiments provide evidence of a causal link between the synaptic strength at D2-MSN in the NAc core and behavioral control over reward-motivated actions.
We also found synaptic potentiation of glutamatergic inputs onto direct-pathway D1-MSNs after cocaine self-administration. Enhanced AMPA/NMDA ratios and other evidence of synaptic potentiation have been seen in D1-MSNs of the NAc after passive cocaine administration 26, 27 . Our results add to previous findings by demonstrating that potentiation of D1-MSNs inputs is a generalized response to cocaine exposure and that it develops in the majority of the mice, independently of whether or not they show compulsive behaviors toward cocaine. In contrast, potentiation at D2-MSN inputs was observed only in the resilient individuals that did not develop compulsive behaviors. It remains unclear whether resilient individuals have stronger inputs to accumbal D2-MSNs, which precede the cocaine exposure, or whether their resilience developed as a consequence of repeated cocaine self-administration. Judging by the range of AMPA/ NMDA ratios that we recorded in sham mice, it is unlikely that the potentiation of D2-MSNs inputs preceded drug exposure. However, further investigation is required to determine the predisposing factors to this resilience. Manipulations of the activity of indirect-pathway neurons in the NAc, even when introduced after several weeks of drug taking, substantially increased or decreased cocaine seeking and self-administration. Systemic administration of a D2-like agonist did not enhance seeking and failed to reproduce the effects of inhibiting D2-MSNs via cell-specific expression of hM4Di. This is possibly a result of the different effects of activation of dopamine D2 receptors expressed on other cell types, such as dopaminergic neurons and cholinergic interneurons. These results highlight the importance of using cell-specific approaches and demonstrate that selective activation of G i signaling in D2-MSNs can increase drug-seeking behavior. The same manipulation did not alter responding for food reward, suggesting that the effect is specific for cocaine seeking. Dorsal regions of the striatum are more likely to be involved, as they regulate cuedinstrumental responding for food 28 . As expected for a strong reinforcer, breakpoint values achieved for food were 10-30-fold higher than those achieved for cocaine. Thus, it is possible that the activity of indirect-pathway neurons is already depressed when responding for such a potent reinforcer and the effect of hM4Di activation might be occluded. When D2-MSNs in the dorsal striatum were inhibited after 3 weeks of cocaine self-administration, responding for cocaine was not increased, suggesting that indirect-pathway neurons in the dorsal striatum are not involved in cued drug seeking at this early stage and under these experimental conditions. D2-MSNs in the NAc core send GABAergic projections to the dorsolateral subregion of the ventral pallidum, where neurons display sustained changes in firing rate that are time locked to responding during a cocaine self-administration task 29 . Reinstatement of cocaine seeking is associated with decreased levels of extracellular GABA in the ventral pallidum, and blockers of glutamateric transmission in the NAc core prevent the change 30, 31 . These findings implicate indirect D2-MSNs in NAc and its projections to the ventral pallidum in the processing of drug-seeking behavior and inhibitory control of the output. It is tempting to speculate that selective silencing of ventral pallidum neurons would also decrease the motivation to seek cocaine. Using therapeutic brain stimulation to enhance indirect pathway or silence the output of ventral pallidum in patients could enhance selfcontrol in those fighting a dependence on stimulant drugs.
In conclusion, our results suggest that synaptic potentiation in D2-MSN inputs is a critical mechanism for controlling the expression of compulsive behaviors toward cocaine. We propose that this cell-specific synaptic potentiation facilitates the recruitment of indirect-pathway neurons and protects against the development of addictive behaviors.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.

ONLINE METhODS
mice. Experiments were performed in accordance with guidelines from the National Institute on Alcohol Abuse and Alcoholism's Animal Care and Use Committee. Drd1-EGFP BAC transgenic mice (GENSAT, Swiss Webster background) and Adora2a-cre BAC transgenic mice (GENSAT, KG139Gsat/Mmcd, SW/B6 background) were used. Mice were housed in groups until surgery and individually afterwards on reversed light cycle (lights on 18:30-06:30) with food and water ad libitum.
Intravenous cocaine self-administration. Mice (~40 d old) were implanted with a chronically indwelling catheter (CamCath) in the right jugular vein as described previously 32 . Mice received oral antibiotics and recovered for 5-7 d before behavioral testing was started. Catheters were maintained by daily flushes with heparinized saline (100-275 U ml −1 ). Sham surgeries permanently occluded blood flow through the jugular vein. Sham control mice (n = 20) were left undisturbed in their home cage for at least 3 weeks in the reversed light cycle before experiments. Modified operant boxes (Med-Associates) (size = 11 × 18 × 13 cm) were used and behavioral testing was performed during the dark phase of the light cycle. Pokes in active hole delivered intravenous cocaine infusions (1-2 mg per kg) paired with the cue light ON for 4 s and a 10-s time out. The house light signaled the drug-off periods and the end of the sessions. Naive mice were trained in 2-6-h sessions for 5-13 d on a fixed poke:reward ratio of 1. The criteria for acquisition of self-administration behavior was a ratio of active:inactive pokes of at least 2.5 and cocaine intake higher than 5 mg per kg per d for the last two training session. An estimated 55% of Swiss Webster Drd1-EGFP mice (27 males, 9 females) reached criteria within 8.5 ± 0.5 d of training and were moved to sessions (2:30 h long, cocaine = 2 mg per kg per infusion) and self-administered cocaine for an average of 31 more days (min = 17, max = 41; Supplementary Table 1 ). The other 45% of the mice (31 mice) did not acquire selfadministration behavior. The behavioral analysis was completed in 28 out of the 36 mice. 8 of 36 mice lost catheter patency right before the last breakpoint session and were used for physiological recordings, but lacked behavioral measurements (Supplementary Table 1 ). Sessions consisted of three drug-on periods (40 min each) interspersed by two 15-min drug-off periods. Perseverance was measured as the number of active pokes during the drug-off periods over the last five sessions. Motivation was measured in two exponentially progressing responding sessions (after days 15 and 30) and the breakpoint was assigned as the motivation value 33 . The motivation and perseverance scores for individual mice were calculated using the z score,
where X i is the behavior value for the individual mouse, X is the mean behavior value for all of the mice included in the study, and s.d. is the standard deviation of the population. The combined behavior score was equal to the sum of the motivation and perseverance scores for each individual mouse.
In experiments using Adora2a-cre +/− mice, sessions were 3:40 h long, the single infusion dose was 1 mg per kg of cocaine, and mice were trained on a fixed ratio of 1, 2 or 3 as mentioned and depending on the experiment. CNO and quinelorane were dissolved in saline and administered intravenously (1 ml kg −1 ) at doses of 1 mg per kg and 0.03 mg per kg, respectively, through the catheter right before the start of the session. Catheter patency was determined every 10 d by anesthetic cocktail (1.5 mg per kg ketamine, 0.75 mg ml −1 midazepan). Mice that failed patency before reaching session 25 were removed from the study. Behavioral data was analyzed and plotted in Igor Pro. The log normal equation were used. Stereotaxic bilateral injections (250-400 nl at 100 nl min −1 ) were performed into the NAc core (anterior-posterior, +1.4 mm; medial-lateral, ±0.1 mm; dorsal-ventral, −4.8 mm, from Bregma) or the dorsal striatum (anterior-posterior, +0.8 mm; medial-lateral, ±1.75 mm; dorsal-ventral, −3.2 mm, from Bregma) of Adora2a-cre +/− and Adora2a-cre −/− mice at 5-6 weeks of age. For self-administration experiments, mice recovered for 3-5 d before indwelling catheters were implanted in the jugular vein. To confirm hM4Di activity using electrophysiological recordings, we injected both Cre-inducible hM4Di-mCherry and ChR2-EYFP vectors (1:1) into NAc core of Adora2a-cre +/− . For in vivo optogenetic stimulation of indirect pathway, a two-ferrule cannula with fiber optics (200 µm/0.22 NA, 4.0 mm, Doric Lenses) was implanted immediately after the viral injection right above the injection area and secured to the skull with metabond and dental cement. Diode-pumped blue lasers (473 nm, 25 mW, CrystaLaser) was used and connected via optic fiber (200 µm/0.22 NA, M25L02, ThorLabs) to a 1in-2out fiberoptic rotary joint (Doric Lenses) to split laser power and facilitate movement during the task. Stimulation consisted of 10-ms pulses delivered at 16.6 Hz for 5 min (2 min for one mouse), mean power output of 5 mW (3.5-6 mW) at each fiber tip of the two-ferrule cannula implanted in the NAc core every 10 min throughout the session. The control mice for these experiments were Adora2a-cre +/− mice injected with AAV-hSyn-DIOmCherry (serotype 5, titer = 6 × 10 12 virus molecules per ml, Gene Therapy Vector Core at University of North Carolina).
electrophysiology. Sagittal slices (250 µm) were prepared from 103 ± 12-d-old mice (n = 35) 4-17 d after last self-administration session and from sham-surgery mice (97 ± 16 d old, n = 20) in cutting solution containing 225 mM sucrose, 119 mM NaCl, 2.5 mM KCl, 0.1 mM CaCl 2 , 4.9 mM MgCl 2 , 26.2 mM NaHCO 3 , 1 mM NaH 2 PO 4 , 1.25 mM glucose, and 3 mM kynurenic acid 26 . Slices were incubated at 33 °C for 30 min and at 22-24 °C until used. Recordings were made at 30 °C using artificial cerebrospinal fluid (ACSF) containing 124 mM NaCl, 2.5 mM KCl, 2.5 mM CaCl 2 , 1.3 mM MgCl 2 , 26.2 mM NaHCO 3 , 1 mM NaH 2 PO 4 and 20 mM glucose. Gabazine (5 µM) and d-serine (10 µM) were added to the ACSF to isolate glutamatergic EPSCs. Whole-cell voltage-clamp recordings were obtained from GFP-positive and GFP-negative MSNs in the NAc core using electrodes (2.5-3.5 MΩ) filled with solution containing 130 mM CsMeSO 4 , 10 mM CsCl, 10 mM HEPES, 0.2 mM EGTA, 4 mM Na-ATP, 0.4 mM Na-GTP and 0.1 mM spermine (pH = 7.25, ~310 mOsm). Recordings were excluded if access resistance was greater than 25 MΩ or if input resistance was greater than the range expected for MSNs (>350 MΩ). eEPSCs were elicited by a pair of current pulses (0.2-ms width, 50-ms interval, every 20 s) using an ACSF-filled glass pipette placed ~250 µm rostro-dorsally. AMPA receptor-mediated eEPSCs were recorded when holding cells at −70 mV. eEPSCs were then recorded at +40 mV in the presence or absence of the NMDA receptor antagonist (R)-CPP (10 µM) and the NMDA receptor response was calculated by subtraction off-line. For currentclamp recording from D2-MSNs, potassium-based internal solution was used. Measurements of D2-MSN output in either core or the ventral pallidum were carried out by whole-cell voltage-clamp recordings using CsCl-based internal solution (all other components were kept the same as described above) while holding the cells at −20 mV in the presence of the AMPA receptor antagonist NBQX (5 µM) to isolate GABAergic IPSCs. IPSCs were evoked by activation of ChR2 and triggered by a brief light pulse (0.2-ms width, 20-s interval) produced by a diode-pumped blue laser (473 nm, 25 mW, CrystaLaser) and delivered via a fiber optic (200 µm/0.22 NA, ThorLabs). All data was analyzed and plotted in Igor. CNO stock was prepared in water and tested at a final concentration of 10 µM in ACSF. Data was acquired using Multiclamp 700B (Molecular Devices), filtered at 1 kHz and digitized at 5 kHz. Electrophysiological recordings were made blind to the behavior score of the mice, except for sham-surgery mice that did not carry an intravenous port and were easily distinguishable to the experimenter. Data was collected from 16 sham-surgery mice and 27 mice after cocaine self-administration within 1-38 d of the last cocaine exposure. Behavioral data was available for 22 mice (5 mice had no behavior; Supplementary Table 1) . Recordings from D1-MSNs were collected in 9 mice, from D2-MSNs in 3 mice, and from D1-MSNs and D2-MSNs in 14 mice. Note that there is no behavioral data for all of them and refer to Supplementary Table 1 for detail.
Two photon glutamate uncaging. A custom-built two-photon laser-scanning microscope equipped with two Ti-Sapphire lasers was used to simultaneously image dendritic spines using a 840-nm laser and photo-release caged glutamate npg next to the spines using a 720-nm laser. Slices and solutions were prepared as described above. Whole-cell recordings were obtained from GFP-positive MSNs in the NAc core region at 25 °C. Alexa Fluor 594 (10 µM) was added to the internal solution to visualize second-and third-order dendrites and spines within 200 µm of the soma were randomly selected for imaging. For all experiments, MNI-glutamate (5 mM), GABAzine (5 µM), TTX (1 µM) and the Ca 2+ channel blockers mibefradil (20 µM) and conotoxin GVIA (1 µM) were added to ACSF. For recordings of AMPA receptor uEPSCs, cells were held at −80 mV and AP5 (5 µM) was added to the external solution. For recordings of NMDA receptor uEPSCs, cells were held at −50 mV and low Mg 2+ (50 µM) ACSF containing NBQX (5 µM) was used. Glutamate uncaging was achieved with a 1-2-ms pulse of 720-nm light delivered next to the spine head every 30 s, and the laser power was standardized in advance by measuring the fluorescence recovery from photobleaching of the red dye in the spine head 34 . Data were acquired using National Instruments data acquisition boards and custom software written in MATLAB 35 . We averaged 10-15 uEPSCs per spine and calculated the peak amplitude in a 1-ms window around the peak. Recordings were collected from D1-MSNs in three cocaine mice and four sham-surgery mice (Supplementary Table 1 ). operant food self-administration. Adora2a-cre +/− and sham Adora2a-cre −/− littermate mice were stereotaxically injected into NAc core with Cre-inducible AAV vectors expressing hM4Di-mCherry and allowed to recover for 9 d. Mice were placed in operant chambers in sound-attenuating boxes (Med Associates) in which they pressed a cued-active lever (left or right, counterbalanced across mice) for an outcome of regular chow pellets (20-mg pellets). Presses on an inactive lever did not result in reinforcement. Mice were food restricted 2 d before training commenced to 90% of their baseline weight, which they were maintained at for the duration of the experiments. On the first day, mice were trained to approach the food magazine (no levers or cue light present) on a random time schedule, with a reinforcer delivered, on average, every 60 s for a total of 30 min. All other training sessions commenced with illumination of the house light, active and inactive lever extension, and illumination of a cue light located directly above the active lever, and ended after 60 min with the levers retracting and the cue and house light turning off. Mice were trained on a FR1 schedule for 3-5 d and, once lever-pressing behavior was acquired, the fixed ratio requirement was increased to FR10. One hour before each session, mice received an injection of saline (10 ml kg −1 , intraperitoneal) during training for habituation and they received either saline or CNO (1 mg per kg dose, 10 ml kg −1 , intraperitoneal) during testing. Testing of FR10 responding began after 3 d of baseline FR10 responding and consisted of 2 d of CNO and 2 d of saline injections. The order of drug test (saline first versus CNO first) was counterbalanced across mice and kept constant across CNO testing. Progressive ratio testing followed in which mice were given CNO or saline on alternating days (counterbalanced across mice) and with a FR10 training session in between progressive ratio test days. The same progressive ratio schedule used for cocaine self-administration was used here 33 with an initial breakpoint of 10, and maximum breakpoint to be achieved of 2012. locomotor assessment. Locomotor activity was recorded in cages (10.25 × 6 inches) constructed out of clear polycarbonate walls and floors under dim illumination (150 lx). Horizontal activity was detected as infrared beam crosses (1-inch spacing, ten beams per cage) made on consecutive beams (ambulatory counts) using Opto M3 activity monitors (Columbus Instruments). The response to the D1 agonist SKF81297 was assessed using a previously described protocol 22 . Briefly, adult mice (8-16 weeks old) were allowed to run freely for 60 min, during which baseline locomotor activity was determined. They received an intraperitoneal injection of either saline or 2.5 mg per kg SKF81297, a dose that increases locomotor activity in wild-type C57BL/6J mice 36 , were immediately returned to the cage and horizontal locomotion was measured for the next 150 min. In all cases, locomotor activity is expressed as the number of ambulatory counts per 10 min, 1 h or normalized to the baseline value obtained for each mouse before drug administration.
Quantitative PcR. Striatal tissue was microdissected from two adult mice (9-16 weeks old) of each genotype (Adora2a-cre +/− and control Adora2a-cre −/− ). All mice received an intra-striatal injection of a viral vector that conditionally expresses hM4Di and 2-4 d of CNO (1 mg per kg) treatment. Total RNA was purified using RNeasy Micro (Qiagen), and cDNA was synthesized using iScript cDNA Synthesis Kit (Bio-Rad). mRNA expression of dopamine D1 receptor Drd1a and the endogenous control gene Actb were determined using TaqMan Gene Expression Assays (Applied Biosystems). Quantitative PCR runs were performed using TaqMan Fast Polymerase (Applied Biosystems) in a StepOnePlus Real-Time PCR system. Cycling conditions were as follows: initial hold at 95 °C for 20 s, 40 cycles of step 1 (95 °C for 1 s) and set 2 (60 °C for 20 s). Samples were run in quadruplicates, and negative controls were run in parallel. cDNA synthesis and quantitative PCR experiments were repeated three times. Relative quantification was calculated using the ∆∆Ct method (StepOne System Software, Applied Biosystems).
Statistics. All statistical comparisons were two-sided and were performed with IGOR or Prism. Paired and unpaired Student's t tests, one-way and repeatedmeasures two-way ANOVA were used when appropriate. Bonferroni tests were used for multiple comparisons post hoc analysis. One sample t test was used to compare normalized breakpoint values of all rewards earned when mentioned. F test was used to compare the variance among groups and test the assumption of normality for each statistical test. In the case of AMPA/NMDA ratios and uncaged-evoked responses at single spines (uEPSCs), the normality assumption was not met and the nonparametric Mann-Whitney test was used instead. All replicates were biological and the errors were calculated as s.e.m. Sample size was not justified with statistical power.
drugs. Cocaine-HCL was obtained from the National Institute on Drug Abuse. Gabazine (SR-95531), (R)-CPP, NBQX, AP5, kynurenic acid and conotoxin GVIA were purchased from Ascent Scientific, MNI-glutamate, mibefradil and quinelorane from Tocris, Alexa Fluor 594 from Molecular Probes, and CNO and all other chemicals from Sigma.
